Skip to main content
Fig. 6 | Journal of Nanobiotechnology

Fig. 6

From: Chitosan-functionalized lipid-polymer hybrid nanoparticles for oral delivery of silymarin and enhanced lipid-lowering effect in NAFLD

Fig. 6

A Effects of chitosan-modified silymarin-loaded lipid-polymer hybrid nanoparticles (CS-LPNs) on alanine transaminase (ALT), aspartate transaminase (AST), cholesterol (CHOL), and triglyceride (TG) levels in serum. B Hematoxylin and eosin staining results (scale bar, 100 μm). (a) Normal diet, (b) chitosan-modified silymarin loaded-LPNs (CS-LPNs), (c) silymarin-loaded LPNs (S-LPNs), (d) silymarin suspension (S-suspension), (e) high-fat diet (HFD). C Oil Red O staining results (scale bar, 50 μm). (a) Normal diet, (b) CS-LPNs, (c) S-LPNs, (d) S-suspension, (e) HFD

Back to article page